B.C.'s health minister to raise alarm over baby-gender test [Canada]
By Vancouver Sun,
Vancouver Sun
| 08. 15. 2005
B.C. Health Minister George Abbott says he plans to contact his federal counterpart, Ujjal Dosanjh, this week to express his alarm about a test kit available for sale over the Internet that apparently makes it possible for a woman to find out the gender of a fetus as early as five weeks into her pregnancy.
"This is something that is of much concern to me," he said in an interview Sunday. "Gender testing should only be done in early stage pregnancy when it's medically necessary."
He will also bring his concerns about the test to a scheduled meeting of provincial and territorial health ministers in the fall if necessary, he said.
Not only is the province concerned about the possibility that the test could be used by couples to terminate a pregnancy based on the sex of the embroyo, there is no way to determine the reliability of the testing kit.
"We really have no way of knowing of the quality of the kits and whether in fact the predictability of the kits and accuracy of the kits ....
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Isabel van Brugen, Newsweek | 06.05.2025
A U.S.-based biotech company has unveiled a new in vitro fertilization (IVF) option that allows parents to select embryos based on genetic markers tied to health and longevity.
DNA testing and analysis company Nucleus Genomics has announced the world's first...
By Jonathan D. Grinstein, PhD, Inside Precision Medicine | 06.03.2025
On Tuesday, 307 days after he was first admitted to Children’s Hospital of Philadelphia (CHOP), KJ Muldoon went home after being successfully treated with the first personalized CRISPR gene editing therapy. KJ, who was born with a serious and...
